8
Oct
2024

Korea Arlico Pharm Co., Ltd.

Exhibitor at CPHI Milan 2024 stand 4D72, API
About Us

Korea Arlico Pharm successfully overcame tons of obstacles ‘Together’ for 30 years of journey and became one of 50 major pharma companies in Korea, listed at KOSDAQ in 2018. Our sales networks & sales power nationwide made the consistent annual sales growth showing the average growth rate up to 23% from 2015 to 2022. CMO specialized business company of generic pharmaceuticals at PIC/S GMP facility. 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • KR
  • 2023
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 4D72, API

Products Featured at CPHI Milan 2024

  • Arlicough Tab (Levodropropizine 60mg)

    Product Arlicough Tab (Levodropropizine 60mg)

    Levodropropizine is a cough suppressant. It is the levo isomer of dropropizine. It acts as a peripheral antitussive, with no action in the central nervous system. It does not cause side effects such as constipation or respiratory depression which can be produced by opioid antitussives such as codeine and i...
  • UDCA Tab (Ursodeoxycholic acid 200mg)

    Product UDCA Tab (Ursodeoxycholic acid 200mg)

    Ursodeoxycholic acid is a naturally occurring bile acid that is used to dissolve cholesterol gall stones and to treat cholestatic forms of liver diseases including Primary Biliary Cirrhosis (PBC).

Korea Arlico Pharm Co., Ltd. Resources (1)